Trxade Health acquires Scienture in all-stock transaction valued at $103M
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 26 2024
0mins
Source: SeekingAlpha
Business Combination Announcement: TRxADE HEALTH has completed an all-stock business combination with Scienture, acquiring all of Scienture's assets in exchange for TRxADE stock.
Future Plans and Focus: The combined company will be renamed "Scienture Holdings" and aims to develop innovative branded specialty pharmaceutical products to enhance healthcare standards and provide value to patients and caregivers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
